An indictment unsealed on Monday charged the former chief scientific officer of biopharmaceutical company Humanigen with engaging in an insider trading scheme involving the firm's stock, the U.S.
A former U.S. citizen is facing serious charges of insider trading, which is a significant legal development in the biopharmaceuticals and banking industries. The charges, unsealed today, involve Dale ...
Some results have been hidden because they may be inaccessible to you